Isabela Bussade

Medications originally developed to treat metabolic diseases, such as Mounjaro, have come to occupy a central place in conversations about health, behavior and relationship with the body. The interview proposes to discuss the scientific advancement behind these therapies, their indicated uses, the necessary precautions for responsible adoption and the social, economic and public health impacts that this new generation of medications may generate in the medium and long term.